Endothelial β2 adrenergic signaling to AKT:: Role of Gi and SRC

被引:51
作者
Ciccarelli, Michele
Cipolletta, Ersilia
Santulli, Gaetano
Campanile, Alfonso
Pumiglia, Kevin
Cervero, Pasquale
Pastore, Lucio
Astone, Dalila
Trimarco, Bruno
Iaccarino, Guido
机构
[1] Univ Naples Federico II, Dept Clin Med Cardiovasc & Immunol Sci, I-80131 Naples, Italy
[2] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA
[3] Univ Naples Federico II, Dept Biochem & Med Biotechnol, I-80131 Naples, Italy
[4] CEINGE Adv Biotechnol, Naples, Italy
关键词
endothelium; receptors; g protein; molecular biology; vascular biology;
D O I
10.1016/j.cellsig.2007.05.007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have recently demonstrated that endothelial beta(2) adrenergic receptors beta(2)AR regulate eNOS activity and consequently vascular tone, through means of PKB/AKT. In this work we explored the signal transduction pathway leading to AKT/eNOS activation in endothelial cells (EC). Using pharmacological and molecular inhibitors both in cultured EC cells and in ex vivo rat carotid preparations, we found that G(i) coupling of the beta 2AR is needed for AKT activation and vasorelaxation. Since endothelial activation is sensitive to pertussis toxin but not to G(i beta gamma), inhibition by beta ARKct, we conclude that G(alpha i) mediates beta AR induced AKT activation. Downstream, beta AR signalling requires the soluble tyrosine kinase SRC, as both in cultured EC and rat carotid, the mutant dominant negative of SRC prevent beta(2)AR induced endothelial activation and vasodilation. In EC, G(alpha i) directly interacts with SRC and this interaction leads to SRC activation and phosphorylation in a manner that is regulated by Balk stimulation. We propose a novel signal transduction pathway for beta(2)AR stimulation trough G(alpha i) and SRC, leading to activation of AKT. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1949 / 1955
页数:7
相关论文
共 40 条
[1]   RETRACTED: β-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates β-adrenoceptor switching from Gs to Gi (Retracted Article) [J].
Baillie, GS ;
Sood, A ;
McPhee, I ;
Gall, I ;
Perry, SJ ;
Lefkowitz, RJ ;
Houslay, MD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) :940-945
[2]   Dual regulation of Akt/protein kinase B by heterotrimeric G protein subunits [J].
Bommakanti, RK ;
Vinayak, S ;
Simonds, WF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (49) :38870-38876
[3]   Evidence against β3-adrenoceptors or low affinity state of β1-adrenoceptors mediating relaxation in rat isolated aorta [J].
Brahmadevara, N ;
Shaw, AM ;
MacDonald, A .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (01) :99-106
[4]  
BREDT DS, 1992, J BIOL CHEM, V267, P10976
[5]   PROTEIN-KINASE-B (C-AKT) IN PHOSPHATIDYLINOSITOL-3-OH INASE SIGNAL-TRANSDUCTION [J].
BURGERING, BMT ;
COFFER, PJ .
NATURE, 1995, 376 (6541) :599-602
[6]   Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases [J].
Butt, E ;
Bernhardt, M ;
Smolenski, A ;
Kotsonis, P ;
Fröhlich, LG ;
Sickmann, A ;
Meyer, HE ;
Lohmann, SM ;
Schmidt, HHHW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) :5179-5187
[7]   Switching of the coupling of the beta(2)-adrenergic receptor to different G proteins by protein kinase A [J].
Daaka, Y ;
Luttrell, LM ;
Lefkowitz, RJ .
NATURE, 1997, 390 (6655) :88-91
[8]   Akt is a direct target of the phosphatidylinositol 3-kinase - Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells [J].
Datta, K ;
Bellacosa, A ;
Chan, TO ;
Tsichlis, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (48) :30835-30839
[9]   Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation [J].
Dimmeler, S ;
Fleming, I ;
Fisslthaler, B ;
Hermann, C ;
Busse, R ;
Zeiher, AM .
NATURE, 1999, 399 (6736) :601-605
[10]   Activation of nitric oxide synthase by β2-adrenoceptors in human umbilical vein endothelium in vitro [J].
Ferro, A ;
Queen, LR ;
Priest, RM ;
Xu, BA ;
Ritter, JM ;
Poston, L ;
Ward, JPT .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (08) :1872-1880